Clinical trial

A Study of Apabetalone in Subjects With Long -COVID

NCT06590324

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-04-15

PhasePHASE2 / PHASE3

Study timeline

Study start (actual)2025-04-15Date precision: day

Registry last updated2025-04-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Post-Acute COVID-19 Syndromeunresolved

Interventions

ApabetaloneDRUG

Sponsors & collaborators

Resverlogix Corplead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06590324 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.